Brokerages forecast that Imperva Inc (NASDAQ:IMPV) will post sales of $86.40 million for the current quarter, Zacks reports. Four analysts have provided estimates for Imperva’s earnings, with the highest sales estimate coming in at $87.30 million and the lowest estimate coming in at $85.80 million. Imperva reported sales of $72.31 million in the same quarter last year, which indicates a positive year over year growth rate of 19.5%. The business is scheduled to issue its next quarterly earnings report on Thursday, May 3rd.

On average, analysts expect that Imperva will report full year sales of $86.40 million for the current year, with estimates ranging from $372.00 million to $383.00 million. For the next financial year, analysts expect that the company will post sales of $433.41 million per share, with estimates ranging from $422.00 million to $439.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Imperva.

Imperva (NASDAQ:IMPV) last released its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a negative return on equity of 3.37% and a net margin of 7.11%. The company’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 EPS.

A number of equities analysts have recently weighed in on IMPV shares. Piper Jaffray Companies cut Imperva from an “overweight” rating to a “neutral” rating and set a $42.00 price target for the company. in a report on Monday, October 16th. Royal Bank of Canada reiterated a “buy” rating and set a $49.00 price target on shares of Imperva in a report on Wednesday, October 18th. Evercore ISI set a $56.00 price target on Imperva and gave the stock a “buy” rating in a report on Thursday, October 19th. KeyCorp reiterated a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Finally, Zacks Investment Research upgraded Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 price target for the company in a report on Tuesday, October 24th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.93.

Imperva (NASDAQ:IMPV) traded up $4.50 during midday trading on Thursday, hitting $46.55. The stock had a trading volume of 2,140,000 shares, compared to its average volume of 343,454. The stock has a market cap of $1,580.00, a PE ratio of 69.48 and a beta of 1.79. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $52.40.

Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new position in Imperva during the 3rd quarter worth about $134,000. First Quadrant L P CA acquired a new position in Imperva during the 3rd quarter worth about $136,000. Ameritas Investment Partners Inc. raised its position in Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its position in Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after purchasing an additional 866 shares in the last quarter. Finally, Amalgamated Bank acquired a new stake in Imperva in the 2nd quarter valued at about $206,000. 96.61% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://theolympiareport.com/2018/02/11/imperva-inc-impv-expected-to-announce-quarterly-sales-of-86-40-million.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.